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ABSTRACT
The regular supply of radiopharmaceuticals and radioimmunoassay
kits from BARC has been an important factor in the deveIopment  of
nuclear medicine in India.  However,  a major stumbling block has been
the non-avai labi l i ty  of  sui table  instrumentat ion systems (especial ly the
computer-assisted gamma camera) at an affordable price. Two recent
developments, viz., the creation of the Board bf Radioisotope
Technology by the Department of Atomic Energy, and the efforts of
Electronic Corporation of India Ltd. to design indigenously a gamma
camera with a computer attachment,  hold promise for the future healthy
and rapid growth of nuclear medicine in the country.  Training in nuclear
medicine at the post-graduate level is gradually picking up.
Nuclear medicine is essentially applied physiology and
biochemistry, and provides an orientation,different from those of the
anatomist and physiologist. The gamma camera, SPECT and PET
+nable  the study of dynamic metabolic function in health and disease,
adding the dimension of functional resolution to spatial and temporal
resolutions.  Newer developments in tagged monoclonal  ant ibodies  hold
promise for a better understanding of infectious and inflammatory
diseases which are a burden in the developing countries.
1. INTRODUCTION
It gives me great pleasure to write this article for the Brig. Mazumdar
Commemoration Issue of the Defence  Science Journal. I and Dr. Mazumdar were
contemporary post-graduate students at the Hammersmith Hospital, London in
1956-57. Both of us had passed the MRCP examination and were looking for future
avenues of service to the country on our return. Radioisotope techniques had just
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then newly arrived in clinical medicine and the Hammersmith Hospital was the first
in the world to have a hospital-based cyclotron installed in 1955 (a machine that is
still working). The defence department of Govt. of India asked Dr. Maxumdar to get
trained in radioisotope techniques, which he accepted rather grudgingly because
basically he was a good clinician and enjoyed examining and treating patients rather
than dealing with measuring instruments or test tubes in the laboratory. The choice
was good for the country because this culminated ultimately in the creation of the
Institute of Nuclear Medicine and Allied Sciences. Today it stands as a monument to
the memory of Dr. Mazumdar.
2. NEED FOR COLLECTIVE EFFORT
The regular supply of reactor-produced radiopharmaceuticals  and
radioimmunoassay kits from the Isotope Division of Bhabha Atomic Research Centre
(BARC) has been a major factor in the development of nuclear medicine in India.
Unfortunately the biggest stumbling block has been the non-availability of suitable
instruments at an affordable price. The vision and dynamism of Homi Bhabha and
Pandit Jawaharlal Nehru ensured that atleast  in the peaceful applications of nuclear
energy there was no time lag,whereas in all other areas of science and technology
India was lagging behind by twenty to two hundred years. But this vision and dynamism
has not been reflected in the field of indigenous manufacture of gamma cameras and
computers which are essential for fully exploiting the useful potential of nuclear
medicine in India. Two recent developments have been most encouraging in this
regard. The Board of Radioisotope Technology (BRIT) was created in 1988 by the
Department of Atomic Energy, with the sole purpose of promoting nuclear medicine
in the country. BRIT will be able to promote regional centres to extend nuclear
medicine services to areas where such facilities do not exist today.
Electronic Corporation of India Ltd. (ECIL) has now been able to make a gamma
camera with a 3/8 in. thick, 16 in. diameter crystal with 37 photomultipliers, which is
suitable for the entire energy range of gamma emitting radionuclides currently
available, and not limited to low energy radionuclides alone, This camera can be used
as a ‘stand-alone’ facility or can be interfaced with a computer (which is also being
developed with indigenous know-how), to .perform  dynamic function studies including
nuclear cardiology. The camera including the computer is expected to be priced at
Rs. 20 lakhs provided Govt. of India grants customs duty exemption for the imported
components, which will eventually be put at 25 per cent of the total cost of the
equipment. Since Govt. of India has already granted duty exemption for radionuclides
like 20177 and 67Ga, it should be possible to get similar exemption for gamma camera-
computer components.
At present there are over 120 medical colleges and their attached hospitals in
India. Nuclear medicine is a subject in the medical curriculum. I have myself
contributed chapters on nuclear medicine and radioimmunoassay (RIA) and nuclear
cardiology in the Text Book of Medicine published by the Association of Physicians
of India and which is read by over 25,000 post-graduate medical students. With the
availability of an affordable gamma camera at about Rs. 10 lakhs, and a
Nuclear  Medicine in India 349
l camera-computer for 20 lakhs, it .can now be expected that within the next five years
nuclear medicine will become a reality in atleast  all medical college hospitals in the
country and through them serve millions of needy patients.
An integral part of this whole scheme is the creation of an infrastructure for
training engineers and technicians for the maintenance and repair of the said
equipment. Adequate storage of appropriate spares and their ready availability is a
mandatory requirement and fortunately there is sufficient technical know-how in this
country for ECIL to undertake this stupendous task.
3. TRACER PRINCIPLE
The most fundamental principle of nuclear medicine is the tracer principle
invented by George Hevesy for which he received the Nobel Prize in 1944. The ability
to administer chemical substances with a radioactive tracer and then follow what
happens to them within the human body gives us the unique capability of studying
and measuring dynamic functions of the various organs of the human body including
the brain. By measuring the spatial distribution of the radibtracer at various intervals
of time, we can determine what is occurring within the body with respect to specific
physiological or biochemical processes, how fast and where such processes are
occmring.  The use of multiple tracers, each measuring a specific body function, adds
the concept of functional resolution to spatial and temporal resolution. These three
concepts are fundamental to nuclear medicine.
4. PET AND SPECT
Since the nuclear medicine images are based on function (for example, uptake
of radioiodine or technetium by the thyroid, radiolabelled phosphate &mpounds  by
the bones, hepatobiliary and renal uptake, myocardial perfusion, brain perfusion,
etc.), the information -is complementary to that provided by other imaging modalities
like radiology, computer&d  tomography (CT), ultrasonography and MFU. Nuclear
medicine is essentially applied physiology and biochemistry and provides an orientation
different from that of the anatomist and pathologist.
Nuclear medicine was the first medical imaging science to use computers for data
acquisition, processing, display and quantification, which paved the way for CT and
digital angiography. The most recent advance in nuclear medicine is the positron
emission tomography (PET). We can now look at ‘slices of life’ to examine the regional
chemistry of the living human body including the brain, in health and disease. Slices
indicate the steady growth of PET and the single photon emission computed
tomography (SPECT) in nuclear medicine. As Henry Wagner, the doyan of world
nuclear medicine has aptly put it, if PET is the heart of nuclear medicine today,
SPECT is becoming the muscle and bone. Advances made initially by PET chemistry
are soon translated into compounds for SPECT. One of the major forces in the
advance of nuclear medicine is the development of new radiopharmaceuticals. Since
PET is prohibitively expensive, it is fortunate that new SPECT agents are available
and within reach of Indian nuclear medicine experts. We already have now three
major SPEm b r a i n agentelD1 iodoamphetamine ( I M P ) ,  %Tc
350 R D Lele
hexamethylene-propylene amine oxime (HMPAO) and *Tc ethyl cysteine dimer
(ECD). We also have three SPECT cardiac agen&%Tcisonitrile compotmds;99mTc
boronated agents, and “‘ln-labelled  anti-myosin. SPECT improves the imaging of
labelled  monoclonal antibodies in the detection of colorectal cancer, malignant
lymphoma, ovaries and lung cancer.
5. INFECTION AND INFLAMMATION
India and the developing world have the greatest burden of infectious and
inflammatory disorders. 67Ga has been a useful general purpose ‘search agent’ for the
detection and follow-up treatment of infectious and malignant disorders. In the l!NOs
other alternative approaches are going to be available to us especially those connected
with %Tc which is readily available to us in India. gh”Tc-labelled  AHGA (anti-human
granulocyte antibody) and 99mTc-labelled polyclonal human IgG are promising new
developments.
Since IgG is going to be available as a kit which is much easier and quicker to
prepare than the separation and labelling of leucocytes,  this approach is going to be
the preferred one for us in India for the diagnosis and follow-up of infectious or
inflammatory disorders. In principle it would now be possible to address the clinical
question; where is the septic focus?, by using 99m Tc-labelled polyclonal human IgG,
and then proceed further with the next question; What is the offending agent?, by
using specific monoclonal IgG against the suspect---say pseudomonas, Klebsiella,
Candida,  etc.
6. THE FUTURE OF NUCLEAR MEDICINE
Today’s research will become tomorow’s practice, just as yesterday’s research is
today’s practice. We will continue to have new brain tracers, new heart tracers,
uniquely useful studies that can be performed with no other modality, and cost-effective
studies. Medicine in general has accepted the orientation of nuclear medicine towards
function and chemistry.
The nuclear medicine community in India has great challenges and great
opportunities. Whoever assumes responsibility in nuclear medicine has to maintain
his or her competence at a high level, and ensure rigorous quality control. There is
no place for mediocrity or slopiness in a field which is characterised by a confluence
of several basic disciplines, and which is using highly sophisticated and highly
demanding technology (like SPECT) and which is working at the advancing edge of
medical knowledge.
